Company Active LTD

Company profile

Eagle Genomics Limited

Eagle Genomics | Microbiome Data Science Platform

Unlocking radical innovation by enabling the conversation between microbiome data and the scientist

CRN
06587071
Founded
2008
Age
18

Overview

Legal name
EAGLE GENOMICS LIMITED
Region
London
Registered address
6TH FLOOR 9
APPOLD STREET
LONDON
EC2A 2AP
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller Controls 1
1
Company Active LTD
Eagle Genomics Limited
CRN 06587071
2
Direct and ultimate controller Active LLP
Etf Partners LLP
CRN OC312083

Company events

Reference milestones and recent Companies House filing stream events.

6 events
23 Oct
2024

Liquidation In Administration Progress Report

Insolvency

AM10 | Transaction MzQ0MDAwOTE2OWFkaXF6a2N4 | Paper/PDF filed

Published 24 Oct 2024 06:48

26 Jul
2024

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2023

Accounts due

Accounts Due

Next accounts due date

12 Jul
2023

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2022

Accounts filed

Accounts

Last accounts made up date

07 May
2008

Incorporated

Inception

Company registered at Companies House

Public funding

5 awards
First funded
2011
Funded years
2011, 2012, 2017, 2018, 2024
Age at first award
3 years

Projects

2024 Grant for R&D

A novel barometer for soil health including physical, chemical and microbial elements to guide regenerative and sustainable agriculture

1 Jan 2024 to 31 Dec 2025

Awarded
£0
Total cost £0

Soil microbiomes drive critical functions in agro-ecosystems, including soil fertility, crop productivity and stress tolerance. Previous work demonstrates that agricultural practices influence the link between soil structure and microbiome functionality. System-level agricultural management practices can induce structural alterations, thereby changing the...

2018 Collaborative R&D Lead participant

SteatoSITE - An integrated gene-to-patient data commons for NAFLD research

1 Jul 2018 to 31 Mar 2021

Awarded
£689,781
Total cost £985,401

"We are doing research to improve the health of people who get a kind of chronic liver disease called Non-alcoholic fatty liver disease (NAFLD). Patients who develop NAFLD may go on to develop more serious form of liver disease called non-alcoholic steatohepatitis (NASH), which can result in liver fibrosis and liver cancer. Ultimately these patients may n...

2017 Collaborative R&D Lead participant

Increase your data's value: A value-driven semantic enrichment system to speed up scientific insight.

1 Jul 2017 to 30 Jun 2019

Awarded
£577,080
Total cost £824,400

The global life science industry spends billions of dollars annually on research innovation. This activity generates huge volumes of data e.g. clinical, omics with the potential to generate powerful innovation insights to drive business decisions, but dicovering and understanding data assets can account for up to 80 percent of the cost of an eResearch stu...

2012 Vouchers Lead participant

Genomics and Agronomic Trait Analysis

1 Nov 2012 to 31 Mar 2013

Awarded
£5,000
Total cost £5,000

In this project the performance of a bioinformatics tool kit will be evaluated within an oil seed rape breeding programme. We will test the tool kit on large data sets to identify molecular genetic markers associated with oil content. The project will help Eagle Genomics to access new markets in crop breeding.

2011 Collaborative R&D Lead participant

Cloud Analytics for Life Sciences

1 Jul 2011 to 31 Dec 2012

Awarded
£103,052
Total cost £267,170

High-throughput technologies, such as microarrays or Next Generation Sequencing (NGS), are revolutionising life science research. These technologies are already having an impact on plant and animal breeding, research into crop protection and more importantly in human health. The cost of generating these data is falling, but the ongoing cost of supplying l...

Product types

Collaborative R&D Grant for R&D Vouchers